Schedule 13D ownership disclosure

AEVI GENOMIC MEDICINE INC

Security class unavailable · CUSIP: 00835P105

Event date: 2020-01-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
57,280,927
Percent of class
49.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-001508
Form type
SC 13D/A
Filer
Aevi Genomic Medicine, LLC
CIK
CIK 1138776
Filed
Jan 06, 2020
Reporting period
Jan 06, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub